These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. [Lung cancer: progress in diagnosis and treatments. Topics: III. Treatment; 1. Surgery, sublobar resection and adjuvant and neoadjuvant therapy for non small cell lung cancer]. Miyata Y; Okada M Nihon Naika Gakkai Zasshi; 2014 Jun; 103(6):1293-9. PubMed ID: 25151793 [No Abstract] [Full Text] [Related]
47. Lung cancer resection rate is related to survival. Lau KK; Waller DA; Rathinam S; Page R; Peake MD Thorax; 2013 Feb; 68(2):187. PubMed ID: 23143791 [No Abstract] [Full Text] [Related]
48. Surgical resection of lung cancer in England: more operations but no trials to test their effectiveness. Treasure T; Russell C; Morton D; Macbeth F; Utley M Thorax; 2013 Feb; 68(2):187-8. PubMed ID: 23143841 [No Abstract] [Full Text] [Related]
49. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response. Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420 [TBL] [Abstract][Full Text] [Related]
50. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer. Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470 [TBL] [Abstract][Full Text] [Related]
51. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G; J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834 [TBL] [Abstract][Full Text] [Related]
52. [Place of surgery in a multidisciplinary approach to stage III non-small-cell cancers]. Massard G; Grunenwald D Rev Mal Respir; 1998 Jun; 15(3 Pt 2):396-406. PubMed ID: 9690310 [TBL] [Abstract][Full Text] [Related]
53. Should aggressive surgery ever be part of the management of small cell lung cancer? Waddell TK; Shepherd FA Thorac Surg Clin; 2004 May; 14(2):271-81. PubMed ID: 15382303 [TBL] [Abstract][Full Text] [Related]